Exchange: NASDAQ·Updated 01:06 PM EDT
AXON logo

AXONAxon Enterprise Inc

$521.65
$9.55
(1.80%)
Today
EarningsAug 5
Mkt Cap$42.82B
Vol269,894.00
News
all
press releases
Huntington Ingalls to Post Q2 Earnings: What's in the Cards?
HII heads into Q2 earnings with sales gains expected across segments, while higher G&A costs may pressure profit.
Zacks
More News
Axon Enterprise (AXON) Expected to Beat Earnings Estimates: Should You Buy?
Axon (AXON) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Axon Enterprise (AXON) Beats Stock Market Upswing: What Investors Need to Know
The latest trading day saw Axon Enterprise (AXON) settling at $502.34, representing a +2.12% change from its previous close.
Zacks
Axon vs. Woodward: Which Aerospace & Defense Stock has Better Prospects?
WWD stands out against AXON on valuation and growth, with strong aerospace momentum and shareholder returns supporting its outlook.
Zacks
Axon to Release Second Quarter 2026 Earnings on August 5, 2026
Axon to Release Second Quarter 2026 Earnings on August 5, 2026 Axon to Release Second Quarter 2026 Earnings on August 5, 2026 PR Newswire SCOTTSDALE, Ariz., July 22, 2026 SCOTTSDALE, Ariz., July 22, 2026 /PRNewswire/ -- Axon(Nasdaq: AXON), the global public safety technology leader, today announced...
PR Newswire
Can Axon Enterprise Improve Margin Performance Amid Rising Costs?
AXON is working to offset rising costs through efficiency efforts as it targets stable margins in 2026 and higher profitability by 2028.
Zacks
Axon Enterprise, Inc (AXON) Is a Trending Stock: Facts to Know Before Betting on It
Axon (AXON) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks
Axon Enterprise (AXON) Stock Slides as Market Rises: Facts to Know Before You Trade
Axon Enterprise (AXON) closed the most recent trading day at $511.28, moving 3.07% from the previous trading session.
Zacks
Beat the Market the Zacks Way: Liquidia, BILL, Colgate-Palmolive in Focus
LQDA, BILL and Colgate-Palmolive highlight recent Zacks picks as multiple portfolios outperformed or posted strong stock gains despite market volatility.
Zacks
Is Axon (AXON) a Buy as Wall Street Analysts Look Optimistic?
According to the average brokerage recommendation (ABR), one should invest in Axon (AXON). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Zacks
<
1
2
>

Advertisement|Remove ads.